scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1022160402 |
P356 | DOI | 10.1186/1471-2334-9-17 |
P932 | PMC publication ID | 2652463 |
P698 | PubMed publication ID | 19216752 |
P5875 | ResearchGate publication ID | 24010001 |
P2093 | author name string | Jianjun Chen | |
Ze Chen | |||
Fuyan Wang | |||
Liyun Zheng | |||
Haiyan Chang | |||
Zhongdong Yang | |||
P2860 | cites work | Protection against influenza B virus infection by immunization with DNA vaccines. | Q45738887 |
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. | Q45741835 | ||
Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses | Q45741950 | ||
Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines | Q45783780 | ||
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens | Q45863237 | ||
Gene transfer into muscle by electroporation in vivo. | Q51501466 | ||
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. | Q55041754 | ||
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine | Q68059682 | ||
The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl | Q71261654 | ||
Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine | Q73091967 | ||
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza | Q77122492 | ||
Development of Hemagglutinin Subtype–Specific Reference Antisera by DNA Vaccination of Chickens | Q79200729 | ||
Influenza: emergence and control | Q24562911 | ||
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations | Q24563751 | ||
The evolution of H5N1 influenza viruses in ducks in southern China | Q24564166 | ||
Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? | Q24684322 | ||
Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 | ||
Probable person-to-person transmission of avian influenza A (H5N1) | Q28304014 | ||
Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control | Q29301392 | ||
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans | Q30233717 | ||
Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. | Q30326724 | ||
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. | Q30327047 | ||
Influenza: lessons from past pandemics, warnings from current incidents. | Q30351160 | ||
Pandemic influenza: a zoonosis? | Q30351209 | ||
Immunogenicity of novel consensus-based DNA vaccines against avian influenza. | Q30359911 | ||
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. | Q30363500 | ||
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. | Q30372127 | ||
Protection against a lethal avian influenza A virus in a mammalian system | Q30432414 | ||
DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. | Q30432708 | ||
Avian influenza A (H5N1) in 10 patients in Vietnam | Q34301283 | ||
Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. | Q34416715 | ||
Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery | Q35868177 | ||
Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. | Q35881308 | ||
Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin | Q35882175 | ||
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. | Q38389069 | ||
Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice | Q40297409 | ||
Strategies to improve protection against low-pathogenicity H7 avian influenza virus infection using DNA vaccines | Q40623731 | ||
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation | Q40879555 | ||
Effective construction of DNA vaccines against variable influenza genes by homologous recombination. | Q40895786 | ||
Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong | Q42609736 | ||
Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks | Q43176631 | ||
Avian influenza. Human transmission but no pandemic in Indonesia | Q43176769 | ||
Avian influenza. Journal letter spotlights China's bird flu reporting | Q43176774 | ||
The Impact of Avian Influenza Viruses on Public Health | Q43217580 | ||
Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents | Q43492081 | ||
Treatment of canine nasal aspergillosis with enilconazole | Q44865737 | ||
A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months | Q45305000 | ||
Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation | Q45456530 | ||
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. | Q45729695 | ||
DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes | Q45732765 | ||
P4510 | describes a project that uses | electroporation | Q1142521 |
P921 | main subject | avian influenza | Q43987 |
electroporation | Q1142521 | ||
immunization | Q1415366 | ||
P304 | page(s) | 17 | |
P577 | publication date | 2009-02-12 | |
P1433 | published in | BMC Infectious Diseases | Q15759919 |
P1476 | title | A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice | |
P478 | volume | 9 |